Marco Mele
Randers, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.
Journal: ESMO open
Published: December 17, 2025
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial.
Journal: ESMO open
Published: June 05, 2025
Antibodies toward Na+,HCO3--cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer.
Journal: British journal of cancer
Published: September 20, 2023
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer.
Journal: Breast cancer research : BCR
Published: January 18, 2023
Diagnostic challenges of adenomyoepithelioma: A case report.
Journal: Breast disease
Published: July 11, 2022
Breast-Conserving Surgery or Mastectomy?: Impact on Survival.
Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: May 09, 2022
Amplified Ca2+ dynamics and accelerated cell proliferation in breast cancer tissue during purinergic stimulation.
Journal: International journal of cancer
Published: December 16, 2021
Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 13, 2019
Inflammatory breast cancer: A review from our experience.
Journal: Breast disease
Published: July 01, 2019
Last Updated: 09/26/2026